Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Multifactorial Approach to Emergent Cerclage (RECIA)

This study has been completed.
Information provided by (Responsible Party):
William Grobman, Northwestern University Identifier:
First received: April 29, 2010
Last updated: November 5, 2014
Last verified: November 2014

April 29, 2010
November 5, 2014
March 2010
March 2013   (final data collection date for primary outcome measure)
Gestational Latency Achieved Between Cerclage Placement and Time of Delivery [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
Median gestational latency achieved Between Cerclage Placement and Time of Delivery
Gestational latency achieved between cerclage placement and time of delivery [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT01114516 on Archive Site
  • Gestational Latency of More Than 28 Days [ Time Frame: 28 days postpartum ] [ Designated as safety issue: No ]
    The frequency of achieving a gestational latency of more than 28 days
  • Gestational Age at Delivery [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
    Median gestational age at delivery
  • Neonatal Morbidity and Mortality [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Days spent in the neonatal intensive care unit
  • Birthweight [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
    Median birthweight
  • Gestational age at delivery [ Time Frame: 24 weeks ] [ Designated as safety issue: No ]
  • Neonatal morbidity and mortality [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    NICU days, birthweight
Not Provided
Not Provided
Multifactorial Approach to Emergent Cerclage
Role in Emergent Cerclage of Indomethacin and Antibiotics

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is unknown whether the use of tocolytics and antibiotics prolongs pregnancies complicated by need for emergent cerclage.

The objective is to determine whether administration of peri-operative antibiotics and indomethacin to patients receiving emergent cerclages for cervical insufficiency increases latency period to delivery compared with patients receiving emergent cerclage alone.

Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Cervical Insufficiency
Drug: Indomethacin and antibiotics (cefazolin or clindamycin)
q8hr dosing of po indomethacin 50mg X 24 hrs and q8 hr 1 g IV cefazolin or 600 mg IV clindamycin
Other Name: indocin, cleocin, ancef
  • No Intervention: control
    emergent cerclage with no peri-operative antibiotics or indomethacin
  • Experimental: indomethacin and antibiotics
    perioperative antibiotics and indomethacin
    Intervention: Drug: Indomethacin and antibiotics (cefazolin or clindamycin)
Miller ES, Grobman WA, Fonseca L, Robinson BK. Indomethacin and antibiotics in examination-indicated cerclage: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1311-6. doi: 10.1097/AOG.0000000000000228.

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
March 2014
March 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • GA 16+0 to 23+6 weeks
  • Singleton gestation
  • Presence of cervical dilation as diagnosed on digital examination
  • Intact membranes

Exclusion Criteria:

  • Age <18 years
  • Allergy to NSAIDs
  • Renal disease
  • Allergy to penicillins AND clindamycin
  • Currently on antibiotics or indomethacin for any reason
  • HIV positive
  • Pregnancies complicated by fetal congenital anomalies
  • Preterm premature rupture of membranes
  • Fever of 100.4 degrees Fahrenheit or higher
  • Any patient having received a therapeutic cerclage during the current pregnancy
18 Years to 80 Years
Contact information is only displayed when the study is recruiting subjects
United States
William Grobman, Northwestern University
Northwestern University
Not Provided
Not Provided
Northwestern University
November 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP